Abstract. Temperature-sensitive mutations in the SEC16 gene of Saccharomyces cerevisiae block budding of transport vesicles from the ER. SEC16 was cloned by complementation of the sec16-1 mutation and encodes a 240-kD protein located in the insoluble, particulate component of cell lysates. Secl6p is released from this particulate fraction by high salt, but not by nonionic detergents or urea. Some Secl6p is localized to the ER by immunofluorescence microscopy. Membrane-associated Secl6p is incorporated into transport vesicles derived from the ER that are formed in an in vitro vesicle budding reaction. Secl6p binds to Sec23p, a COPII vesicle coat protein, as shown by the two-hybrid interaction assay and affinity studies in cell extracts. These findings indicate that Secl6p associates with Sec23p as part of the transport vesicle coat structure.
a 240-kD protein located in the insoluble, particulate component of cell lysates. Secl6p is released from this particulate fraction by high salt, but not by nonionic detergents or urea. Some Secl6p is localized to the ER by immunofluorescence microscopy. Membrane-associated Secl6p is incorporated into transport vesicles derived from the ER that are formed in an in vitro vesicle budding reaction. Secl6p binds to Sec23p, a COPII vesicle coat protein, as shown by the two-hybrid interaction assay and affinity studies in cell extracts. These findings indicate that Secl6p associates with Sec23p as part of the transport vesicle coat structure.
Genetic analysis of SEC16 identifies three functionally distinguishable domains. One domain is defined by the five temperature-sensitive mutations clustered in the middle of SEC16. Each of these mutations can be complemented by the central domain of SEC16 expressed alone. The stoichiometry of Secl6p is critical for secretory function since overexpression of Secl6p causes a lethal secretion defect. This lethal function maps to the NH2-terminus of the protein, defining a second functional domain. A separate function for the COOH-terminal domain of Secl6p is shown by its ability to bind Sec23p. Together, these results suggest that Secl6p engages in multiple protein-protein interactions both on the ER membrane and as part of the coat of a completed vesicle.
T
RANSPORT vesicles mediate the movement of protein cargo between the organelles of the secretory pathway (Palade, 1975) . The yeast Saccharomyces cerevisiae has been useful for identifying genes required for the proper function of these transport vesicles. Through the use of genetic screens and purification of proteins active in cell-free transport assays, ~20 yeast gene products have been identified that act in vesicle transport between the ER and Golgi apparatus (for review see Pryer et al., 1992) . Some of these gene products appear to be evolutionarily conserved since mammalian homologues have been isolated that have been shown to complement SEC gene function or to be located in the transitional region between the ER and Golgi apparatus in mammalian cells (Wilson et al., 1989; Orci et al., 1991; Griff et al., 1992; Hosobuchi et al., 1992; Kuge et al., 1994; Shaywitz et al., 1995) .
pronounced effect on mutations in SEC genes that act later in the secretory pathway (Kaiser and Schekman, 1990) . These stage-specific genetic interactions show that at 25°C, sEcl6 alleles impair vesicle formation at the ER. Further, secl6 mutations are partially suppressed by overexpression of SAR1, a small GTP-binding protein that is required for ER to Golgi transport (Nakano and Muramatsu, 1989) . The functions of SAR1, SEC12, and SEC23 constitute a GTP hydrolysis cycle coupled to vesicle formation. Sec23p stimulates GTPase activity of Sarlp (Yoshihisa et al., 1993) , and Sec12p stimulates exchange of GTP for GDP by Sarlp . The genetic interactions outlined above suggest that the function of SEC16 may also relate to this GTPase cycle. Sec16p could generate a local signal that acts on the Sarlp GTPase cycle; alternatively Sec16p could be acted upon by a signal generated by Sarlp.
In this paper, we describe the isolation of SEC16 and the characterization of its product. Sec16p was found to be both on the ER and on vesicles that had budded from the ER. Moreover, the COOH-terminal domain of Sec16p is shown to bind to Sec23p, indicating that Sec16p is part of the vesicle coat structure and may serve as a platform for incorporation of cytosolic proteins into the vesicle coat. A genetic dissection of SEC16 identifies at least three functionally distinguishable domains of the protein. Analysis of Sec16p and its association with other vesicle components will likely uncover many of the subunit interactions that are important for transport vesicle assembly and integrity.
Materials and Methods
Strains, Media, and Recombinant DNA Techniques Table I lists the S. cerevisiae strains and Table II describes the plasmids used in this study. Standard genetic manipulations and yeast transformations were performed as described (Kaiser et al., 1994) . Unless otherwise noted, cultures were grown in synthetic complete (SC) medium with the indicated carbon source and without the supplements appropriate for selection. DNA manipulations were performed using standard techniques (Sambrook et al., 1989) . PCR was performed using Taq polymerase according to the manufacturer's specifications (Perkin-Elmer Cetus, Norwalk, CT).
Cloning and Sequencing of SECI6 and SEC16 Mutations
SEC16 was isolated from a library of S. cerevisiae genomic sequences in YCp50 (Rose et al., 1987) . Insert sequences from a plasmid that complemented secl6-1 were subcloned into the centromere, URA3 vector pRS316 (Sikorski and Hieter, 1989) . The smallest complementing subclone contained a 7.2-kb BamHI-SphI genomic fragment. Deletion derivatives were produced by digestion of linear plasmid DNA with exonuclease III and $1 (Henikoff, 1987) . Using nested deletions from both ends of the cloned DNA as the templates, the gene was sequenced following the protocol for the Sequenase kit (United States Biochemical Corp., Cleveland, OH). Gaps in the sequence were filled using synthetic oligonucleotide primers that matched the sequence of the first strand.
To test for linkage between the cloned sequences and the SEC16 locus, the integrating plasmid YIp352 (Hill et al., 1986 ) with a SphI-StuI fragment containing ~ the COOH-terminal two-thirds of SEC16 was directed to integrate at the homologous chromosomal locus by cleaving the plusmid in the insert sequences with PstI before transformation of CKY8. Two transformants were crossed to CKY51 and tetrads showed complete linkage of the plasmid sequences to secl6-2.
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formed several tests to establish that the putative initiation ATG preceded by in-frame stop codons was in fact the start of translation. First, a frame-shift mutation was generated by a 2-bp deletion at a SaclI site at the codon for amino acid 103. A clone with this mutation did not complement a secl6-2 mutation, indicating that the SaclI site was within the SEC16 coding sequence. Second, a fusion to the GALl promoter was constructed to initiate translation at the putative initiation ATG (pPE4). This plasmid was shown to express functional SEC16 by complementation of a chromosomal deletion of SECI6. To show that SEC16 expressed from the GALl promoter initiated at the wild-type initiation codon, both wild-type SEC16 and SEC16 expressed from the GALl promoter were fused at amino acid 103 to the SUC2 gene. The size of fusion proteins expressed from the wildtype promoter and the GALl promoter were identical as determined by SDS-PAGE and Western blotting with anti-invertase antibodies (not shown).
Five temperature-sensitive secl6 mutations were mapped by marker rescue recombination with plasmid-borne SEC16 sequences (Falco et al., 1983) . A secl6 mutation to be mapped was transformed with each of a nested set of deletion plasmids. To stimulate mitotic recombination between the plasmid sequences and chromosomal SEC16, transformant cultures were exposed briefly to light from germicidal lamps such that ~50% of the cells survived. Temperature-resistant recombinants, scored after plating at 37°C, arose only if the deletion did not remove the site of the mutation.
Once located by deletion mapping, each of the mutant alleles was cloned by gap repair of plasmid pCK1615 containing a gap within the SEC16 sequences produced by cutting with XbaI and BstXI before transformation (Rothstein, 1991) . The base changes responsible for the mutations were obtained by sequencing the appropriate deletion interval using synthetic oligonucleotide primers.
SECI6 Deletion
A chromosomal deletion secl6-AI::TRP1 that replaced all but the first 103 amino acids of SEC16 coding sequence with TRP1 was made by the method of ~ transformation (Sikorski and Hieter, 1989) . The disruption plasmid, pPE113, contained both a 0.4-kb KpnI~tuI fragment from the 3' noncoding sequence and a BamHI-SacII fragment containing 5' sequences and the first 103 codons inserted into pRS304 (TRP1). A trpl diploid, CKY19, was transformed with linearized pPE113 to yield CKY233 with a heterozygous chromosomal disruption of SEC16 that extended from amino acid 103 to 30 basepairs past the end of the gene. Integration was confirmed by Southern blot analysis (ECL kit; Amersham Corp., Arlington Heights, IL).
Construction of GAL Promoter Fusions
SEC16 was fused to the GALl promoter in pCD43 (Shaywitz et al., 1995) using the primer 5'-GCGGATCCAAGAATGACACC]?GAAGCCAAG-3' and PCR to create a junction between the BamHI site (underlined) adjacent to the GALl promoter and the beginning of the SEC16 coding sequence (bold). The plasmid expressing full-length SEC16 from the GALl promoter, pPE4, contained the complete coding sequence of SEC16 extending to the StuI site in the 3' noncoding sequence inserted into the BamHI-SmaI sites of pRS315. An NH2-terminally truncated GALl promoter fusion, pPE38, that contained amino acids 565-2194 of Secl6p was made using the primer 5'-GCGGATCCAACCATGCGTCAAGAGCAAGTrC-3' to create the junction between an ATG codon at position 565 and the BamHI site adjacent to the GALl promoter. A third GALl promoter fusion, pPE46, that contained amino acids 1017-2194 of Sec16p was made using the primer 5'-TI"GGATCCATGATTTCATCAAG-CATTGTAC-3' to create the junction between an ATG codon at position 1017 and the BamHl site adjacent to the GALl promoter.
Construction of Invertase Fusions
A plasmid pPE12 was created to fuse portions of SEC16 to the cytoplasmic form of invertase, encoded by SUC2. The plasmid pPE12 has the XhoI-SacII polylinker of pBluescript (Stratagene Inc., La JoUa, CA) fused to SUC2 by use of the following oligonucleotide primer: 5'-TC-CCCGCGGCATCAATGACAAACGAAAC-3'. The SacII site is underlined and the ATG for the internal form of invertase is in bold face. All of the SEC16-SUC2 fusions were expressed from the GALl promoter and Table II lists the amino acids of SEC16 contained in each fusion.
Epitope Tagging of SE C16
The epitope-tagged SEC16-HA was constructed as follows: a 2-kb PstINotI fragment of pPE4 was subcloned into pBluescript-SK+ (Stratagene Inc.). Oligonucleotide site-directed mutagenesis was used to insert a NotI site between amino acids 1892 and 1893 of SEC16 (Kunkel et al., 1987) . The oligonucleotide sequence was 5'-CATCGCCTGCTATATATG-CAGGCGGCCGCAGAACTCACCAAGCACATGC-3'. This plasmid was partially digested with NotI, and a 100-bp NotI-NotI fragment from pGTEPI (Tyers et al., 1993) , containing three tandem copies of the hemagglutinin epitope recognized by the 12CA5 mAb (BAbCO, Richmond, CA), was inserted (Kolodziej and Young, 1991) . The epitope-tagged fragment of SEC16 was inserted into the full-length SEC16 plasmid, pPE8 to generate full-length SEC16-HA, pPE26.
Carboxypeptidase Y (CPY) Immunoprecipitation
To analyze cells overexpressing Sec16p, a strain carrying plasmid pPE4 expressing SEC16 from the GALl promoter (CKY232) was grown at 30°C to exponential phase in minimal medium containing 2% raffinose and 3% glycerol. Expression from the GALl promoter was induced in medium containing 2% galactose for 10 h. To analyze cells with decreased levels of Sec16p, a strain with a chromosomal deletion of SEC16 carrying pPE4 (CKY247) was grown at 30°C to exponential phase in SC medium containing 1% glucose and 1% galactose. Sec16p expression was shut off by growth in medium containing 2% glucose for 15 h. The secl6-2 strain (CKY50) was grown at 25°C, then 37°C for 1 h. Cultures were labeled for 10 min at a concentration of ~1 × 108 cells/ml using 150 ixCi/ml of 35S-radiolabeled cysteine and methionine (Expre 35S35S, DuPont-NEN, Boston, MA). After 10 min, the chase was initiated by addition of cysteine and methionine to a final concentration of 30 and 40 Ixg/ml, respectively. An aliquot of 2 x 107 cells was removed at time points and lysed using NaOH as described below for Western blots. The resulting extract was resuspended in 50 ~.1 sample buffer (80 mM Tris-HCl, pH 6.8, 2% SDS, 0.1 M DTr, 10% glycerol, and 0.01% bromophenol blue) and heated at 95°C for 5 min. CPY isolated from extracts by immunoprecipitation was analyzed by gel electrophoresis and autoradiography (Laemmli, 1970; Rothblatt and Schekman, 1989) .
Electron Microscopy
CKY50 carrying secl6-2 was grown at 25°C in yeast extract/peptone/dextrose medium (YPD) to exponential phase (N1 × 107 cells/ml) and shifted to 37°C for 1 h. To prepare cells depleted of Secl6p, a strain with a chromosomal deletion of SEC16 carrying a plasmid with SEC16 expressed from the GALl promoter (CKY237) was grown at 30°C to exponential phase in medium containing 1% glucose and 1% galactose, diluted into medium containing 2% glucose, and grown for 16 h. Cells were prepared for electron microscopy by fixation with glutaraldehyde and KMnO4 (Kaiser and Schekman, 1990) . Fixed, dehydrated cells were embedded in Spurr's resin and were sectioned to a thickness of ~70 nm. Sections were stained with a 1:5 dilution of Reynold's lead citrate for 2.5 min (Reynolds, 1963) to enhance membrane profiles and were viewed in an electron microscope (1200CX; JEOL USA, Analytical Instruments Division, Cranford, N J) at 80 kV.
Sec l 6p Antiserum
Sec16p antiserum was elicited against a hybrid protein composed of a segment of Sec16p fused to Staphylococcal protein A. A 1.4-kb PvulI-PstI fragment encoding 460 amino acids from the central region of SEC16 was inserted into protein A fusion vector pRIT31 (Nilsson and Abrahmsen, 1990) . Fusion protein was prepared from Escherichia coli extracts and antibody to this protein elicited as previously described (Griff et al., 1992) .
The serum was affinity purified using a 13-galactosidase-Secl6p hybrid protein constructed in the vector pEX1 by fusing to lacZ the same PvulIPstI fragment of Secl6p used in the protein A fusion (Stanley and Luzio, 1984) . The hybrid protein was isolated and used for affinity purification of the antibody as described (Griff et al., 1992) .
Western Blotting
Yeast cultures were grown to exponential phase (~1 x 107 cells/ml) in YPD or SC medium containing either 2% glucose or, for Sec16p overexpression, 2% raffinose and 3% glycerol followed by growth in 2% galactose for 4.5 h. Cell extracts were prepared by suspending ~6 × 107 cells in 100 t~l medium and adding 17 txl 1.85 M NaOH, 1 M 13-mercaptoethanol for 10 min at 4°C (Yaffe and Schatz, 1984) . Proteins were precipitated with TCA, washed with acetone, dried, and resuspended in 0.1 ml sample buffer by heating to 100°C. Protein extracts were assayed for total protein using the DC protein assay (Bio-Rad Laboratories, Hercules, CA). Protein samples were separated by electrophoresis on a gel of 6% polyacrylamide, 0.375 M Tris-HC1, pH 8.8, 0.1% SDS without a stacking layer. Electrophoretic transfer of proteins to nitrocellulose was performed in the presence of 0.1% SDS (Harlow and Lane, 1988) . Proteins were detected using a 1:500 dilution of 12CA5 mouse mAb (BAbCO) and a 1:10,000 dilution of anti-mouse IgG, peroxidase coupled whole antibody from sheep (Amersham Corp.), or a 1:500 dilution of affinity-purified anti-Sec16p rabbit polyclonal antibody and a 1:10,000 dilution of anti-rabbit IgG, peroxidase-linked whole antibody from donkey (Amersham Corp.). Western blots were developed using chemiluminescence (ECL kit; Amersham Corp.).
Cell Fractionation
To analyze the subcellular distribution of Sec16p, a wild-type strain (CKY10) was grown at 30°C in YPD to exponential phase. 2 x 109 cells were suspended in 50 ml 0.1 M Tris sulfate, pH 9.4, 28 mM 13-mercaptoethanol for 10 min at 25°C, and then spheroplasted for 1 h at 30°C using 3,700 U lyticase in 10 ml spheroplasting buffer (2% yeast extract, 1% peptone, 10 mM Tris-HC1, pH 8.0, 0.7 M sorbitol). Metabolic activity was regenerated by aeration of spheroplasts in YPD with 0.7 M sorbitol for 1 h at 30°C. Cells were washed in 0.7 M sorbitol, 0.1 M NaCI, 10 mM Tris-HC1, pH 8.0, 5 mM MgCI2, and gently lysed in 0.5 ml cell lysis buffer (20 mM MES, pH 6.5, 0.1 M NaCI, 5 mM MgCI2, and protease inhibitor cocktail) using 0.3 g of acid-washed glass beads. The inhibitor cocktail consisted of I mM PMSF, 10 p.g/ml E-64, 0.5 ~g/ml leupeptin, 0.7 ~g/ml pepstatin, 2 ~g/ml aprotinin, and 0.5 U/ml ct2-macroglobulin (all Boehringer Mannheim Biochemicals, Indianapolis, IN) (Jones, 1991) . Cell lysis was complete as judged by light microscopy. After lysis, the cell extract was subjected to a series of centrifugation steps using an ultracentrifuge rotor (TLA100; Beckman Instruments, Palo Alto, CA): 500 g for 20 min; 10,000 g for 30 min; and 150,000 g for 60 min, all at 4°C.
Extraction of Secl6p from the particulate fraction was tested by treating 0.1 ml cell extract with 1% Triton X-100, 0.1 M sodium carbonate (pH 11.5), 2.5 M urea or 0.5 M NaC1. Samples were incubated at 4°C for 1 h and separated into soluble and particulate fractions by centrifugation at 150,000 g for 1 h at 4°C. In both experiments, samples representing equal amounts of cell extract were solubilized in sample buffer and analyzed by Western blotting as described above.
Indirect Immunofluorescence
The intracellular location of Secl6p was examined by indirect immunofluorescence performed essentially as described (Pringle et al., 1991) . A diploid yeast strain expressing SEC16 from the GALl promoter (CKY241) was grown at 30°C to early exponential growth phase (106-107 cells/ml) in SC medium containing 2% raffinose and 3% glycerol. To facilitate localization, Sec16p was overexpressed by transferring the cells to medium containing 2% galactose for 2 h before fixation.
Ceils were fixed for 1 h with 3.7% formaldehyde in the medium. A 10-ml culture was collected by centrifugation and then spheroplasted with 100 U lyticase in 0.1 M potassium phosphate, pH 7.5, 28 mM 13-mercaptoethanol for 30 min at 30°C. Antibody incubations were performed on coverslips in a humid chamber at 25°C for 1 h. Sec16p was detected using a 1: 100 dilution of affinity-purified See16p antibody and a 1:500 dilution of anti-rabbit Ig-FITC antibody (Boehringer Mannheim Biochemicals). Samples mounted in medium containing 4,6-diamidino-2-phenylindole (DAPI) and p-phenylenediamine were photographed with an axioscope (Carl Zeiss, Inc., Thornwood, NY) using hypersensitized Technical Pan Film 2415 (Lumicon, Livermore, CA) at ASA400 and developed using D-19 (Eastman Kodak Co., Rochester, NY) for 4 min at 23°C (Schulze and Kirschner, 1986) .
In Vitro Vesicle Synthesis and Purification
Membranes and cytosol used in the vesicle synthesis reaction were prepared as previously described with the exception that donor membranes were collected at 12,000 g . Membranes from CKY283 were prepared from spheroplasts that were lysed gently with glass beads in the presence of protease inhibitors. Cytosol was prepared from CKY93 without added guanine nucleotide. Guanine nucleotides were later added as indicated to budding reactions at a final concentration of 0.1 mM. A standard vesicle synthesis reaction of 1 ml contained 200 Ixg membranes, 2.4 mg cytosol, 1 mM GDP-mannose, 0.1 mM guanine nucleotide, and an ATP regeneration system in reaction buffer (20 mM Hepes-KOH, pH 6.8, 150 mM KOAe, 5 mM MgOAc, 250 mM sorbitol) with protease inhibitors (Wuestehube and Sehekman, 1992) . The reaction with apyrase added contained 10 U/ml apyrase in the place of the ATP regeneration system. Reactions were incubated at 20°C for 2 h unless otherwise noted. Donor membranes were removed by centrifugation of Eppendorf tubes at 17,000 rpm (12,000 g) for 10 min at 4°C in a rotor (TLA 100.3; Beckman Instruments, Inc., Palo Alto, CA). Vesicles were collected from the supernatant by centrifugation at 60,000 rpm for 30 min at 4°C in a TLA 100.3. Vesicle pellets were solubilized in sample buffer and proteins were analyzed by Western blotting using either the 12CA5 mAb, a 1:1,000 dilution of Sec22p polyclonal antibody (gift of Dr. Charles Barlowe, Dartmouth Medical School, Hanover, NH), or a 1:1,000 dilution of Sec61p polyclonal antibody (gift of Dr. Randy Schekman, University of California, Berkeley, Berkeley, CA). Protein detected by Western blotting was quantitated by densitometry using an Ultroscan (2202; LKB Instruments, Inc., Gaithersburg, MD). The protease inhibitor cocktail used for these experiments contained 1 mM PMSF, 10 ~,g/ml E-64, 0.5 p.g/ml leupeptin, 0.7 }xg/ml pepstatin, 2 i~g/ml aprotinin, 50 ~g/ml antipain, 1 mg/ml Pefabloc, 0.1 mg/ml phosphoramidon, 40 ixg/ml bestatin, and 0.25 U/ml a2-macroglobulin (all Boehringer Mannheim Biochemicals).
Vesicles formed in vitro from donor membranes prepared at 32,000 g were fractionated by gel filtration on a 14-ml (18 cm) Sephacryl S-1000 column (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated in reaction buffer as described (Barlowe et al., 1994) . A 0.7-ml sample of the 32,000 g supernatant from a 1.0-ml reaction was applied to the column, eluted with reaction buffer, and 0.75-ml fractions were collected. Vesicles in each fraction were concentrated by centrifugation at 60,000 rpm for 30 min at 4°C in a TLA 100.3 rotor. Proteins solubilized in sample buffer were analyzed by Western blotting. Column fractions were also assayed for total protein using the DC protein assay kit.
Two-Hybrid Protein-Protein Interaction Assay
Potential interactions between Sec16p and Sec23p were investigated using the two-hybrid protein interaction assay and the plasmids pEG202, pJG4-5, and pSH18-34 (Gyuris et al., 1993) . Plasmids derived from pEG202 contained the lexA DNA-binding domain fused to fragments of Sec16p: amino acids 1645-2194 (pPE58), 1-824 (pPE59), and 447-1737 (pPE74). The full-length coding sequence of SEC23 was fused to an acidic transcriptional activator in the plasmid pJG4-5 to create pPE81.
Combinations of control or fusion protein plasmids together with a reporter plasmid, pSH18-34, were transformed into the strain EGY40 (Golemis and Brent, 1992) . Positive interactions were scored as blue colonies on SC medium (pH 7.0) containing 2% galactose and 40 mg/1 X-gal. 13-galactosidase activity was assayed as described (Kaiser et al., 1994) . Strains were grown to exponential phase in SC medium containing 2% raffinose and 3% glycerol. 10 h before the assay galactose was added to a final concentration of 2% to induce production of the acidic activator protein. Activity was normalized to total protein determined by the Bradford assay (Bio-Rad Laboratories).
Affinity Isolation of Sec l 6p and Sec23p
The full-length coding sequence of SEC23 was fused to the glutathione-Stransferase (GST) gene (Smith and Johnson, 1988) expressed from the GALl promoter to create pPEll9, a derivative of pRD56 (the kind gift of Dr. Ray Deshaies, California Institute of Technology, Pasadena, CA). To produce a soluble and detectable COOH-terminal domain of SEC16, we used plasmid pPE86 that expressed the COOH-terminus of Sec16p-HA (amino acids 1638-2194), from the GALl promoter. Binding was tested in extracts from CKY282 transformed with pPE119 and pPE86.
Protein extracts were prepared from cells grown to exponential phase in SC medium, then for 4 h in SC medium containing 2% galactose. 108 cells were lysed using glass beads in extraction buffer (20 mM Hepes-KOH, pH 6.8, 80 mM KOAc, 5 mM MgOAc, 0.02% Triton X-100) with protease inhibitor cocktail. The extract was diluted to 1 ml with extraction buffer and the lysate was cleared by centrifugation at 13,000 g for 2 min. Glutathione Sepharose 4B beads (Pharmacia Fine Chemicals) were added and samples were incubated for 1 h at 25°C. Beads were washed three times in 1 ml extraction buffer and once in buffer without Triton X-100. Proteins were solubilized in sample buffer and resolved by SDS-PAGE on a 7% gel. Lysate samples were prepared by adding 5× sample buffer to an aliquot of cleared lysate. Proteins were transferred to nitrocellulose and Western blots were developed as described above.
Results

Isolation and Sequence of SECI6
A genomic library in the centromere vector YCp50 (Rose et al., 1987) was screened for clones that complemented sec16-1 at 38°C. A complementing 7.2-kb BamHI-SphI fragment was isolated. This segment was shown to contain the authentic SEC16 locus by directing integration of a plasmid carrying this fragment to the homologous chromosomal site, and showing that the integrated plasmid sequences were tightly linked to sec16-2 by segregational analysis.
The 7.2-kb complementing fragment was sequenced and an open reading frame encoding 2,194 amino acids was found. The predicted amino acid sequence is shown in Fig.  1 a and the nucleotide sequence is available from Genbank. SEC16 did not appear to be closely related to other genes in the database, but two features of the sequence are noteworthy. Overall, the sequence was hydrophilic with no obvious signal sequence or transmembrane domains, suggesting a cytoplasmic protein. In addition, the sequence contained three regions with a high density of prolyl and glycyl residues and with few charged or hydrophobic residues; amino acids 581-1050 (18% P and G), amino acids 1501-1800 (15% P and G), and amino acids 2076-2175 (32% P and G). The other regions of the protein had an unusually high density of both basic and acidic residues. The domains rich in residues that disrupt secondary structure could be extended linkers connecting charge-rich domains.
Temperature-sensitive Alleles
Five recessive temperature-sensitive mutations in SEC16 have been isolated: sec16-1 and sec16-2 were found in the original screen for sec mutations (Novick et al., 1980) a nested set of SEC16 deletions (Falco et al., 1983) . The mutations were recovered onto plasmids by gap repair, and the appropriate region of the plasmid clone was sequenced. The five mutations were located near the middle of the gene; sec16-1 changed Trp 1230 to Arg, secl6-2 and sec16-5 were identical and changed Leu 1088 to Pro, secl6-3 changed Leu 1083 to Pro, and sec16-4 changed Leu 1058 to Ser (see Fig. i b) . A series of SEC16 deletions was constructed on a high copy vector to find the regions of SEC16 necessary for complementation of the sec16 alleles. The NH2-terminus was not required for complementation since a truncation of SEC16 that removed the first 565 codons (pPE129) complemented all sec16 alleles (Fig. 2) . Complementation depended on the truncated allele being expressed from a 2tx vector and transcription presumably was initiated within vector sequences. Extensive COOH-terminal deletions partially complemented in the sense that sec16 mutant strains carrying the truncated allele on a plasmid grew slowly at 36°C, whereas strains carrying the vector only did not grow at all at this temperature, pPE131 (amino acids 565-1475) partially complemented both sec16-1 and secl6-2, and pPE132 (amino acids 565-1171), which had lost the site of the sec16-1 mutation, partially complemented secl6-2, but did not complement sec16-1 (Fig. 2) . This intragenic complementation behavior shows that the central domain of SEC16 can, by itself, provide some function lost in the sec16 mutants, and therefore ascribes a discrete function to the central portion of the protein.
NH2-terminal Domain of SEC16 Is N o t Essential
A null allele of SEC16 was constructed by replacing the sequences from amino acid 103 to beyond the end of the coding sequence with the TRP1 gene. This allele, secl6-Ah:TRP1, behaved as a recessive lethal since a heterozygous diploid segregated as two viable and two dead ascospores on sporulation and none of the viable spore clones carried the TRP1 marker.
The ability of truncated SEC16 to complement temperature-sensitive alleles suggested that parts of SEC16 may not be essential. We tested the plasmid-borne truncations of SEC16 for the ability to complement secl6-Ah:TRP1 by segregational analysis in diploids heterozygous for secl6-Ah:TRP1 (Fig. 2) . The NH2-terminus of Sec16p (amino acids 1-564) was not essential since viable segregants car- and sec16-1 (CKY52) by plasmids bearing different truncations was tested by growth at 36°C. Complementation of sec16-AI::TRP1 at 30°C was tested by segregational analysis of diploids heterozygous for the SEC16 null allele (CKY233). Complementation of the sec-16-ZI1::TRP1 allele by pPE4 was assayed by plasmid shuffle on medium containing 1% glucose and 1% galactose and 5-fluoro-orotic acid (Boeke et al., 1984) . Plasmids pPE8, pPE26, and pPE4 are low copy, centromere plasmids. Plasmids pPE129, pPE130, pPE131, pPE132, and pPE133 are high copy, 21~ plasmids. Shaded bars and amino acid numbers indicate the portion of SEC16 contained on the plasmid. rying pPE129 covering the chromosomal deletion could be isolated, pPE130, which has the COOH-termina130 amino acids deleted, was also tested. No segregants carrying pPE130 covering the chromosomal deletion were found in 20 tetrads dissected showing that the COOH-terminus of Secl6p was essential.
Depletion o f Sec l 6p
To test whether loss of Secl6p resulted in a phenotype similar to that of the temperature-sensitive (ts) mutations, we examined cells depleted of Sec16p. To do this a gene fusion was made that placed the expression of SEC16 under control of the G A L l promoter. Full expression of SEC16 from the G A L l promoter on 2% galactose is toxic to cells (see below). However, growth on medium containing 1% glucose and 1% galactose gave modest expression of Secl6p that was not toxic. A strain with G A L l regulated SEC16 covering secl6-AI::TRP1 on the chromosome (CKY247) allowed SEC16 expression to be shut off by growth in glucose. ER to Golgi transport was measured by following the maturation of the vacuolar protease CPY. In a pulse-chase experiment, the core-glycosylated pl form of the CPY proenzyme in the ER is converted to the p2 form by further glycosylation in the Golgi apparatus and finally is proteolytically processed in the vacuole to give the mature (m) form (Fig. 3, lanes 1-3) (Stevens et al., 1982) . When CKY247 grown in medium containing 1% glucose and 1% galactose was transferred to 2% glucose medium, the cells stopped growing within 15 h. The cessation of growth was accompanied by a complete block in the conversion of CPY from the pl to p2 form (Fig. 3,  lanes 4-6) . This defect in ER to Golgi transport is comparable to that in a secl6-2 mutant at the restrictive temperature (Fig. 3, lanes 13-15) .
The phenotype that results from depletion of Sec16p was examined more closely by electron microscopy. CKY247 was grown in glucose medium for 16 h to develop a secretory block due to depletion of Secl6p. These cells were fixed and stained with permanganate to visualize membranes. The mutant cells accumulated excess ER membranes to a similar degree as that of sec16-2 at the restrictive temperature (Fig. 4, b and c) . Importantly, there was no accumulation of 40-50 nm vesicles as observed in mutants defective in vesicle fusion such as secl7 and sec18 (Kaiser and Schekman, 1990) . Thus, like the ts alleles of SEC16, depletion of Secl6p appears to block vesicle budding.
Secl6p Is Lethal When Overexpressed
We found that a high copy, 2Ix plasmid carrying SEC16 transformed yeast at a very low frequency, suggesting that overexpression of Sec16p was toxic to cells. The effect of SEC16 overexpression was examined systematically using the inducible G A L l promoter. A wild-type strain expressing SEC16 from the G A L l promoter was viable in medium containing 2% glucose, but did not grow in 2% galactose medium. Truncations of SEC16 were used to map the portion of the protein responsible for the toxicity on Figure 3 . Depletion or overexpression of SEC16 causes a block in ER to Golgi transport. A Gal +, secl6-AI::TRP1 strain carrying a plasmid with SEC16 expressed from the GALl promoter (CKY247) was grown in 1% glucose and 1% galactose (lanes 1-3) or glucose only for 15 h to deplete cells of Secl6p (lanes 4-6). A Gal + strain with a plasmid expressing SEC16 from the GALl promoter (CKY232) was grown in glucose (lanes 7-9) or induced in galactose for 10 h (lanes 10-12) . CKY50, a secl6-2 ts strain, was grown at 37°C for 1 h to express a secretion block (lanes 13-15) . Cultures were labeled with 35S-translabel for 10 min and chased by the addition of excess unlabeled methionine and cysteine for 10 and 30 rain. CPY was immunoprecipitated from labeled extracts and resolved by SDS-PAGE. The three forms of CPY are labeled pl (ER), p2 (Golgi), and m (vacuole).
overproduction. Fig. 5 shows the growth on galactose medium of a strain expressing truncations of SEC16 from the GALl promoter. Strains expressing the full-length protein (pPE4) did not grow on galactose. Removal of amino acids 1-564 allowed slow growth on galactose. A more extensive deletion of the NH2-terminus to beyond the first proline-rich region allowed for full growth on galactose and placed the toxic domain in the first half of the protein (Fig. 5, pPE46) . Deletions from the COOH-terminus using SEC16-SUC2 fusions also showed that the toxic portion of the protein lay in the NH2-terminal domain and did not include the region where the point mutations were located (Fig. 5) . Taken together, the behavior of the trun- cated proteins suggested that the first proline-rich region was the principle cause of lethality on overexpression. However, a test of the toxicity of this proline-rich region alone gave weak growth on galactose, suggesting that flanking regions contribute to either the toxicity or the conformational stability of this protein domain.
The effect of SEC16 overexpression on ER to Golgi transport was examined by following the maturation of CPY. After induction of GALl expression of SEC16, CPY maturation did not progress beyond the pl form indicating a block in transport to the Golgi apparatus (Fig. 3, lanes  10-12) . This block was similar to that produced by either depletion of Secl6p or a sec16-2 mutation (Fig. 3, lanes 4--6  and 13-15) .
Since either depletion or overexpression of Secl6p blocked ER to Golgi transport, the sec16 ts mutations could act either by reduction or hyperactivation of SEC16 function. Reduction of function seemed the more likely possibility since the ts alleles were recessive. We performed an additional explicit test of the mode of action of the ts mutations. Each of the four sec16 ts alleles was overexpressed from the GALl promoter and growth was examined at different temperatures. The presence of point mutations decreased the toxicity of SEC16, demonstrating that the mutations act by reducing, not hyperactivating, SEC16 function (data not shown).
Sec16p Detection
To study the SEC16 gene product, we generated antiserum to a protein containing a 460-amino acid segment internal to the SEC16 coding sequence fused to protein A. Antibodies specific for Secl6p were affinity purified with the internal fragment of Secl6p fused to 13-galactosidase. Initial attempts to identify Secl6p on Western blots failed because of two unusual properties of the protein. The protein was extremely labile in vitro and was completely degraded when cell extracts were prepared by boiling in 2% SDS. This proteolysis was eliminated either by lysing the ceils with strong alkali or by preparing the extracts in the presence of protease inhibitors. Once stabilized against degradation, the full-length protein did not migrate through the stacking portion of a Laemmli gel (Laemmli, 1970 ), but we found that the protein could be resolved on a 6% SDS-polyacrylamide gel without a stacking layer. AntiSec16p antibody recognized a protein that migrated above the 190-kD molecular mass marker band (Fig. 6, lane 1) . The identity of Sec16p was confirmed by showing overproduction of this protein in a strain expressing Sec16p from the GALl promoter (Fig. 6, lane 2) .
A second method for Secl6p detection used an epitope tag. Three tandem copies of the 10-amino acid epitope derived from the influenza H A protein were inserted at amino acid 1892 to yield SEC16-HA (Kolodziej and Young, 1991) . SEC16-HA was shown to be fully functional by its ability to complement a null allele (Fig. 2, pPE26) . The 12CA5 mAb recognized a protein in strains expressing SEC16-HA (Fig. 6, lane 4) with the same mobility as the protein detected by Secl6p antiserum.
The extreme lability of Secl6p in extracts prompted us to examine turnover of Secl6p in vivo. Cells expressing SEC16-HA were radiolabeled for 10 min with [35S]methionine and cysteine, and extracts were prepared at times af- Figure 5 . The NH~-terminal domain is lethal when overexpressed. CKY96, a Gal ÷ strain, was tested for the ability to grow when expressing different SEC16 gene fragments from the GALl promoter on galactose medium at 30°C. + + indicates growth indistinguishable from CKY96 carrying vector only, andindicates no growth. The shaded regions and amino acid numbers indicate SEC16 sequences present in truncations and the fusions to SUC2.
ter addition of unlabeled amino acids. There was no reduction in labeled Sec16p after a 30-min chase (data not shown) showing that the protein is quite stable in vivo.
The abundance of Sec16p in the cell was estimated by two independent means that gave similar results. First, the invertase activity produced in a strain expressing a SEC16-SUC2 fusion protein was used to calculate the cellular content of fusion protein assuming full specific activity of invertase (Goldstein and Lampen, 1975) . The gene fusion contained the SEC16 promoter plus the first 103 codons of Secl6p carried on a centromere plasmid (pPE14) and was expected to be expressed at approximately the same level as endogenous Secl6p. Based on the invertase activity, we calculated that there were 104 molecules of the hybrid protein per cell. The second method compared the intensity of bands on a Western blot using a known amount of bacterially expressed SEC16-lacZ fusion protein as a standard. This estimate gave 4 x 103 Secl6p molecules per cell by assuming that the full-length protein and Figure 6 . Antibody detection of Secl6p. CKY240 (lane 1), a wild-type strain carrying empty vector, and CKY232 (lane 2) expressing SEC16 from the GALl promoter, were induced in galactose medium for 4.5 h at 30°C. CKY238 (lane 3), carrying SEC16 on a low copy plasmid, and CKY239 (lane 4), carrying SEC16-HA on a low copy plasmid, were grown in glucose at 30°C. Extracts were resolved on a 6% SDSpolyacrylamide gel without a stacking layer and Secl6p was visualized by Western blotting. Lanes 1 and 2 were probed using affinity-purified anti-Secl6p antibody. Lanes 3 and 4 were probed with the 12CA5 mAb recognizing the hemagglutinin epitope. fusion protein were electrophoretically transferred and detected with equal efficiency.
Sec16p Localization
The antibody to Secl6p was used to examine the intracellular distribution of the protein. A cell extract from gently lysed spheroplasts was successively centrifuged at 500, 10,000, and 150,000 g. Secl6p detected by immunoblotting was mostly in the 500-g pellet and the remainder was in the 10,000-g pellet (Fig. 7 a) . As a control for cell lysis, the cytosolic form of invertase was shown to be present in the supernatant after sedimentation at 150,000 g (Carlson and Botstein, 1982) . Conditions for release of Secl6p from the particulate fractions were tested by chemical treatments of the cell lysate followed by centrifugation at 150,000 g to test for protein released into the soluble fraction (Fig. 7 b) . Secl6p was not solubilized by nonionic detergents or 2.5 M urea, but was partially released into the soluble fraction by 0.5 M NaC1 or sodium carbonate (pH 11) (Fig. 7 b) . This fractionation behavior was consistent with Sec16p being associated with a membrane or the cytoskeleton (Fujiki et al., 1982; Luna and Hitt, 1992) . As a control for the efficacy of chemical extraction, the fractionation of the integral membrane protein Secl2p and the peripheral membrane protein Sec23p were also followed. Sec12p was solubilized by Triton X-100, but not by the other treatments, and Sec23p was extracted from the particulate fraction by treatment with sodium carbonate (pH 11), 2.5 M urea, and 0.5 M NaC1 (data not shown) (Hicke and Schekman, 1989; Nishikawa and Nakano, 1991) .
The intracellular location of Sec16p was further examined by immunofluorescence microscopy. Wild-type cells stained with affinity-purified anti-Secl6p antibody gave very weak staining. Conditions that gave clear Sec16p staining with a minimum of overproduction were found by examining a diploid strain expressing SEC16 from the G A L l promoter (CKY241) 2 h after induction. Many, but not all, cells showed concentrated staining at the periphery of the DAPI-stained nucleus (Fig. 8, a and b) . Since perinuclear staining is typical of ER proteins (Rose et al., 1989; Deshaies and Schekman, 1990) , the pattern of Secl6p staining was consistent with some of the protein being peripherally associated with the membrane of the ER. Other cells showed punctate staining dispersed through- Figure 7 . Secl6p is in the large particulate fraction of cell extracts and is solubilized by high salt, but not by detergent. (a) A cell lysate of a wild-type strain, CKY10, was subjected to a series of centrifugation steps, resulting in 500-, 10,000-, and 150,000-g pellets (P) and a 150,000-g supernatant (S). An equal number of cell equivalents was loaded in each lane. (b) Cell lysates were separated into pellet (P) and supernatant (S) fractions by centrifugation at 150,000 g after treatment with 1% Triton X-100, 0.1 M sodium carbonate (pH 11.5), 2.5 M urea, or 0.5 M NaC1. Protein samples in both a and b were analyzed by SDS-PAGE and Western blotting using anti-Secl6p antibody.
out the cell body suggesting that Sec16p was also located at sites other than the ER. The observed staining was specific for Secl6p because antibody against the H A epitope gave similar results with a strain overexpressing SEC16-HA, while no staining was seen in a strain overexpressing untagged SEC16.
Sec l6p Copurifies with ER to Golgi Transport Vesicles
Since some Sec16p appeared to be on the ER, we tested directly for Sec16p on budded ER to Golgi transport vesicles produced in vitro. Transport vesicles will bud from isolated ER membranes in the presence of GTP and cytosol at 20°C (Groesch et al., 1990; Rexach and Schekman, 1991; Barlowe et al., 1994) . To test for association of Sec16p with vesicles formed in vitro, partially purified ER microsomes isolated from a strain expressing SEC16-HA were incubated with GTP and cytosol at 20°C. Sec16p-HA behaved identically to Sec16p in all cell fractionation experiments, and therefore Sec16p-HA was used to facilitate the detection of Sec16p (data not shown). Because Sec16p-HA was insoluble, the only source of Sec16p-HA in this reaction was the microsomal fraction. A crude vesicle fraction was obtained by removing donor membranes from the reaction by centrifugation at 12,000 g and then collecting vesicles by centrifugation at 100,000 g. As expected for a vesicle protein, Sec16p-HA entered the vesicle fraction under conditions that promote vesicle formation from the ER; Sec16p-HA was in the vesicle fraction when incubated with GTP and cytosol at 20°C, but Sec16p-H A in this fraction was greatly reduced when the incubation was carried out at 4°C, with apyrase, or without cytosol (Fig. 9 a) . Sec22p, an integral membrane protein that resides in ER to Golgi transport vesicles, served as a marker for this organelle (Newman et al., 1990; Lian and Ferro-Novick, 1993; Barlowe et al., 1994) . The conditions for release of Sec16p-HA into the vesicle fraction paralleled those for Sec22p (Fig. 9 a) . Fragmentation of the ER was ruled out as a possible source of Sec16p-containing membranes since the resident ER protein Sec61p was not present in this fraction (Fig. 9 a) .
A more definitive test for association of Sec16p-HA with ER to Golgi transport vesicles is to examine whether the vesicles that contain Sec16p-HA behave similarly on gel filtration as Sec22p-containing vesicles. It was shown previously that vesicles formed in the presence of GMP-PNP retain their coat of peripheral membrane proteins, whereas those formed in the presence of GTP do not (Barlowe et al., 1994) . In our assay, GMP-PNP and GTP gave similar levels of vesicle formation (Fig. 9 a, Sec22p) . We chose to use GMP-PNP to produce a population of vesicles that were all coated and therefore would display uni-form characteristics on fractionation. Vesicles synthesized in a reaction using GMP-PNP were separated by gel filtration on a Sephacryl 1000 column. Fractions were sedimented at high speed to collect vesicle pellets which were examined for the presence of Secl6p-HA and Sec22p by Western blotting. Sec22p-containing vesicles eluted as a single peak in the included volume before the elution of most of the total protein (Fig. 9 b) . The elution profile for Secl6p-HA was identical to that for Sec22p. Thus, Secl6p-H A was either associated with the same ER-derived vesicle population as Sec22p or was associated with other vesicles that form under the same conditions and were of the same size.
COOH Terminus of Secl6p Binds Sec23p
The copurification of Sec16p with ER to Golgi transport vesicles prompted us to investigate potential protein-protein interactions between Sec16p and other recognized components of the vesicle coat, using the two-hybrid interaction assay (Fields and Song, 1989; Gyuris et al., 1993) .
Three overlapping fragments of SEC16 (amino acids 1-824, 447-1737, and 1645-2194) were tested independently by fusion to a lexA D N A binding domain. SEC23 and SAR1 each were fused to an acidic activation domain and interaction with each of the SEC16 fragments was tested by assaying activation of transcription of a lacZ reporter gene.
Strong induction of 13-galactosidase activity was observed only when the C O O H terminus of Secl6p (amino acids 1645-2194) was combined with Sec23p (Table III) . This interaction was shown to depend on a functional COOHterminal domain of SEC16 since a parallel experiment conducted with a derivative of the COOH-terminal domain that had the last 30 amino acids removed gave no interaction (not shown). These results indicated that the C O O H terminus of Secl6p binds to Sec23p.
As an independent test for this interaction, binding of the C O O H terminus of Sec16p to Sec23p was examined in yeast cell extracts. The coding sequence of SEC23 was fused to GST expressed from the GALl promoter (Smith and Johnson, 1988 ). The C O O H terminus of Secl6p (amino acids 1638--2194) containing three copies of the hemagglutinin epitope tag (SEC16C-HA) was also expressed from the GALl promoter. We found that, unlike the fulllength Secl6p, a large fraction of the COOH-terminal domain was soluble in cell extracts, thus allowing solution binding studies to be performed. Extracts were prepared from strains overexpressing Sec16Cp-HA and either GSTSec23p or GST only. Proteins bound to GST-Sec23p were isolated on glutathione Sepharose beads, and the presence of Secl6Cp-HA was tested by Western blotting with the 12CA5 mAb. Secl6Cp-HA associated with GST-Sec23p, but not GST, demonstrating dependence on Sec23p (Fig.  10, lanes 1-4) . These experiments demonstrated that the C O O H terminus of Sec16p can form a complex with Sec23p in the soluble fraction of cell extracts.
Discussion
The SEC16 gene had previously been shown to be one of the genes required for the formation of ER transport vesicles in vivo (Kaiser and Schekman, 1990) . SEC16 interacts genetically with SEC23, SEC13, and SAR1, genes whose products are part of a cytosolic protein coat, termed COPII, that encapsulates vesicles assembled from ER membranes in vitro (Barlowe et al., 1994) . Taken together, these results suggested that SEC16 might take part in the formation of the COPII vesicle coat. In this report, Sec16p finds its place as a constituent of COPII-coated vesicles. This conclusion rests on two findings. First, Sec16p appears to be associated with ER-derived vesicles produced in an in vitro budding reaction. When membranes bearing Sec16p are incubated with cytosol, some of the Sec16p is released into a slowly sedimenting fraction in a tempera- SEC16(aa 10.1 -+ 9.4 6.8 -1.8 no fusion 32.9 -12.6 118.9 + 128.6" EGY40 cells transformed by plasmids encoding a lexA fusion protein (pEG202, pPE58, pPE59, or pPE74), an activator domain fusion protein (pJG4-5 or pPE81), and a reporter plasmid (pSH18-34) were grown in galactose for 10 h before the assay to induce expression of fusion proteins. Units of I~-galactosidase activity (nmol/mg × rain) were calculated as (optical density at 420 nm X vol of assay)I(0.0045 X concentration of protein in extract assayed × time). Activities shown were the mean _ SD for three independent transformants. *The three values from this experiment were 20.6, 71.6, and 264.4 units.
ture-and nucleotide-dependent reaction. Release of Secl6p occurs under conditions that closely parallel the behavior of Sec22p, an integral membrane protein marker for ERderived transport vesicles. When the material released from ER membranes is subjected to gel filtration, Secl6p cofractionates with the Sec22p-containing vesicles. These results strongly suggest that Secl6p is coating ER-derived vesicles. We cannot rigorously rule out the possibility that Secl6p is associated with vesicles derived from another source, such as the Golgi apparatus. However, if this is the case, these other vesicles must form under the same conditions and have the same gel filtration properties as vesicles derived from the ER. The principal difficulty in establishing this point is that we have not yet found conditions whereby ER-derived vesicles can be affinity purified with the COPII coats intact. The second finding that indicates Secl6p is part of the COPII coat is that Sec16p binds to the COPII protein Sec23p. Initially, this interaction was detected using the two-hybrid transcription assay when testing for interactions between SEC16 and the COPII genes, SEC23 and SAR1. A strong interaction was only detected for SEC23 in combination with the COOH-terminal domain of SEC16. Binding of these proteins was confirmed by showing that the COOH-terminal domain of SEC16 expressed in yeast cells is found in protein complexes affinity isolated using a GST-Sec23p fusion. The full-length Secl6p was not used in these tests because it is so tightly bound to intracellular membranes that the protein is not available in cell extracts for affinity isolation steps. The simplest interpretation of these results is that Sec23p is in physical contact with the C O O H terminus of Secl6p, however, direct protein-protein contact has not been established. It is possible that a third protein present in the cytoplasm (and in the nucleus for the two-hybrid assay) binds to both Secl6p and Sec23p, providing a link between the two proteins.
ER membranes that have been stripped of peripheral proteins by washing with urea are absolutely dependent on cytosolic proteins for the formation of transport vesicles in vitro (Baker et al., 1988; Salama et al., 1993) . The five purified COPII proteins, Sec23p/Sec24p, Secl3p/ Sec31p, and Sarlp, satisfy the cytosolic requirement, and Figure 10 . Complexes formed between Sec23p and the C O O H terminus of Sec16p. Lanes 1 and 2: CKY282, with both GST-SEC23 (pPEll9) and SEC16C-HA (pPE86). Lanes 3 and 4: CKY282, with GST (pRD56) and SEC16C-HA (pPE86). Lanes 5 and 6: CKY282, with GST-SEC23 (pPEll9) and the empty vector (pRS315). Expression of proteins from the GALl promoter was induced by growth in galactose for 4 h. Lysates from 107 cells were cleared by centrifugation and proteins bound to glutathione Sepharose beads were isolated. Proteins bound to the glutathione beads are in lanes 2, 4, and 6. One-tenth of the total lysate was loaded in the extract lanes 1, 3, and 5. Secl6Cp-HA was detected by SDS-PAGE and Western blot analysis using the 12CA5 mAb.
these proteins become components of a protein coat on the transport vesicles formed in this reaction (Barlowe et al., 1994) . No requirement for exogenously added Secl6p has been detected for the vesicle budding reaction, but a reason for this is now clear. Whereas other peripheral ER proteins, such as Secl3p and Sec23p (Hicke and Schekman, 1989; Pryer et al., 1993) , are removed from ER membranes by washing with urea, we have found that Secl6p is not extracted from membranes by this procedure. Thus, to the extent that Secl6p is needed for budding in vitro, the requirement is presumably satisfied by Secl6p introduced into the budding reaction as a component of the donor ER membranes.
Models for transport vesicle budding have emphasized the role of vesicle coat proteins partitioned between soluble and membrane-bound states. The idea is that vesicle formation is driven by the assembly of soluble coat proteins onto the membrane (Pearse and Robinson, 1990; Rothman and Orci, 1992) . If Secl6p is such a coat protein, the time that it spends off the membrane must be very brief since there is virtually no solubl e Secl6p detected in cell extracts. When Secl6p is localized using cell fractionation and immunofluorescence, some of the protein appears to be associated with the ER. A simple explanation for this behavior is that Sec16p forms a permanent, peripheral membrane coat. The Secl6p that resides on the surface of the ER may be required to recruit other vesicle coat components, such as Sec23p, to the sites of vesicle budding.
The finding that overexpression of SEC16 on a 2ix plasmid or from the G A L l promoter is lethal and blocks ER to Golgi transport suggested that Secl6p could be an inhibitor of vesicle formation. According to this hypothesis, the ts alleles could exert their effect by hyperactivating the inhibitory function. Two genetic experiments argue strongly against this possibility. First, depletion of Secl6p by shutting off regulated expression from the G A L l promoter is lethal and causes a secretion block. Thus, SEC16 performs a positive function in transport and cannot simply be an inhibitor. Second, we tested the effect of mutations on the toxicity of overexpressed SEC16; if the point mutations are hyperactivating, then overexpression of the mutant alleles at high temperature should inhibit growth more than wild-type SEC16. We found that the overexpressed ts alleles are less restrictive than wild-type, and therefore conclude that the ts alleles antagonize the function of SEC16 that causes lethality on overproduction. Thus, there is a critical stoichiometry for Secl6p, and more or less protein causes a lethal secretion defect. This behavior points to a structural role for Sec16p in an assembly whose subunit composition is critical for function and too much or too little Secl6p leads to the assembly of inactive complexes.
The SEC16 sequence contains alternating regions that are either rich in charged amino acids or rich in proline and uncharged residues. Clusters of proline residues have been observed in synaptic vesicle proteins and have been proposed to serve as structural spacers between functional domains (Linial, 1994) . Interestingly, our results indicate that Sec16p is a multifunctional protein, suggesting that the proline-rich regions may serve to connect globular domains that carry out different functions.
Genetic analysis of SEC16 identifies three functionally separable domains that roughly correspond to the central region, NH2-, and the COOH termini of the protein. The five ts mutations are clustered in a 250-bp region of the gene suggesting that the mutations may affect a single function. Internal fragments of SEC16 that contain the central portion of the protein can complement these mutations. This intragenic complementation behavior defines the central region of the protein as an independent functional unit.
We were able to map roughly the portion of the protein that causes a lethal secretion block on overexpression by testing truncated versions of Secl6p for this lethal effect. The critical portion of the protein lies in the NH2-terminal region (amino acids 1-824). This part of the protein may bind to and thereby deplete another factor necessary for vesicle formation. This second domain, defined by overexpression lethality, extends to the middle of the first proline-rich region, but does not overlap with the region containing the point mutations.
Biochemical and genetic experiments identify the COOH terminus as a third functional domain of Sec16p. The COOH terminus of Secl6p (amino acids 1643-2194) and Sec23p interact in the two-hybrid assay and by binding experiments in yeast cell extracts. In the accompanying paper, we show that the cytosolic domain of the ER protein Sed4p also binds to the COOH-terminal domain of Secl6p. Complementation experiments demonstrate that the COOH terminus of SEC16 is essential for the growth of a strain deleted for SEC16. This requirement for the COOH terminus may reflect the need for this domain in binding to Sec23p, Sed4p, and possibly additional proteins.
Collectively, SEC16 functional studies indicate that Secl6p is composed of a number of different functional units. We are now in a position to identify other transport factors that bind to the different regions of SEC16 by affinity purification, genetic suppression screens, or twohybrid screens. Since Secl6p appears to be part of the vesicle coat, sandwiched between membrane proteins and the cytosolic coat proteins, many of the significant subunit interactions in the vesicle coat structure may be revealed by studying proteins associated with SEC16.
